Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02863718
Brief Title: Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression (CLL12)

First Submitted : June 10, 2014
First Submitted that Met QC Criteria : August 10, 2016
First Posted : August 11, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 6, 2019
Last Update Posted : June 7, 2019